Subtopic Deep Dive
Protein Aggregation in Neurodegeneration
Research Guide
What is Protein Aggregation in Neurodegeneration?
Protein aggregation in neurodegeneration refers to the accumulation of misfolded proteins into insoluble inclusions that contribute to neuronal death in genetic disorders like Huntington's and spinocerebellar ataxias.
Misfolded proteins form aggregates via polyglutamine expansions or mutations, impairing cellular clearance pathways such as autophagy and the ubiquitin-proteasome system (Ross and Poirier, 2004; 3415 citations). These inclusions propagate prion-like, exacerbating disease progression (Nishitoh et al., 2002; 1326 citations). Over 20 papers from 2002-2010 detail mechanisms in models like C. elegans and human brain tissue.
Why It Matters
Protein aggregates drive pathology in Huntington's disease, where polyQ expansions form toxic inclusions, as shown in gene expression changes in HD brains (Hodges et al., 2006; 823 citations). Autophagy enhancers like trehalose clear mutant huntingtin and α-synuclein, offering therapeutic strategies (Sarkar et al., 2006; 1105 citations). Targeting aggregation thresholds influenced by aging could delay onset in polyQ disorders (Morley et al., 2002; 823 citations), with applications in frontotemporal dementia via VCP mutations (Watts et al., 2004; 1385 citations).
Key Research Challenges
Aggregate Clearance Failure
Autophagy and multivesicular bodies fail to degrade aggregates in neurodegeneration, as ESCRT mutations impair MVB function (Filimonenko et al., 2007; 623 citations). UPS overload exacerbates inclusion formation in polyQ diseases (Nishitoh et al., 2002). Enhancing mTOR-independent pathways remains inconsistent across models.
Prion-like Propagation
Aggregates spread cell-to-cell via seeding, dynamic in aging C. elegans (Morley et al., 2002; 823 citations). Mechanisms mirror amyloid propagation but lack full genetic dissection. Propagation thresholds vary by protein and region (Hodges et al., 2006).
Toxicity Threshold Dynamics
Aggregation toxicity depends on polyQ length and age, with dynamic thresholds in vivo (Morley et al., 2002). ER stress via ASK1 triggers death from polyQ (Nishitoh et al., 2002; 1326 citations). Quantifying exact thresholds challenges therapeutic design.
Essential Papers
Protein aggregation and neurodegenerative disease
Christopher A. Ross, Michelle A. Poirier · 2004 · Nature Medicine · 3.4K citations
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein
Giles D. Watts, Jill Wymer, Margaret J. Kovach et al. · 2004 · Nature Genetics · 1.4K citations
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
Hideki Nishitoh, Atsushi Matsuzawa, Kei Tobiume et al. · 2002 · Genes & Development · 1.3K citations
Expansion of CAG trinucleotide repeats that encode polyglutamine is the underlying cause of at least nine inherited human neurodegenerative disorders, including Huntington's disease and spinocerebe...
Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein
Sovan Sarkar, J. Eric Davies, Zebo Huang et al. · 2006 · Journal of Biological Chemistry · 1.1K citations
Trehalose, a disaccharide present in many non-mammalian species, protects cells against various environmental stresses. Whereas some of the protective effects may be explained by its chemical chape...
The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in <i>Caenorhabditis</i> <i>elegans</i>
James F. Morley, Heather R. Brignull, Jill J. Weyers et al. · 2002 · Proceedings of the National Academy of Sciences · 823 citations
Studies of the mutant gene in Huntington's disease, and for eight related neurodegenerative disorders, have identified polyglutamine (polyQ) expansions as a basis for cellular toxicity. This findin...
Regional and cellular gene expression changes in human Huntington's disease brain
Angela Hodges, Andrew D. Strand, Aaron K. Aragaki et al. · 2006 · Human Molecular Genetics · 823 citations
Huntington's disease (HD) pathology is well understood at a histological level but a comprehensive molecular analysis of the effect of the disease in the human brain has not previously been availab...
Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled
Paula M. Keeney, Jing Xie, Roderick Capaldi et al. · 2006 · Journal of Neuroscience · 719 citations
Loss of mitochondrial complex I catalytic activity in the electron transport chain (ETC) is found in multiple tissues from individuals with sporadic Parkinson's disease (PD) and is a property of so...
Reading Guide
Foundational Papers
Start with Ross and Poirier (2004; 3415 citations) for aggregation overview, then Nishitoh et al. (2002; 1326 citations) for polyQ mechanisms, and Watts et al. (2004; 1385 citations) for VCP mutations.
Recent Advances
Sarkar et al. (2008; 575 citations) on rapamycin autophagy; David et al. (2010; 639 citations) on aging aggregates in C. elegans.
Core Methods
PolyQ C. elegans models (Morley et al., 2002); autophagy inducers like trehalose (Sarkar et al., 2006); gene expression profiling (Hodges et al., 2006).
How PapersFlow Helps You Research Protein Aggregation in Neurodegeneration
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 3415-citation Ross and Poirier (2004) as central hub, revealing Sarkar et al. (2006) autophagy cluster via findSimilarPapers. exaSearch uncovers prion-like terms across 250M+ OpenAlex papers, surfacing Morley et al. (2002) aging dynamics.
Analyze & Verify
Analysis Agent applies readPaperContent to extract polyQ aggregation data from Nishitoh et al. (2002), then verifyResponse with CoVe checks claims against Hodges et al. (2006) brain expression profiles. runPythonAnalysis quantifies citation overlaps or models threshold dynamics from Morley et al. (2002) using pandas/NumPy, with GRADE scoring evidence strength for autophagy efficacy.
Synthesize & Write
Synthesis Agent detects gaps in clearance mechanisms post-Rubinsztein papers, flagging underexplored VCP-aggregate links from Watts et al. (2004). Writing Agent uses latexEditText, latexSyncCitations for Ross (2004), and latexCompile to generate figure-heavy reviews; exportMermaid diagrams propagation pathways.
Use Cases
"Analyze polyQ aggregation thresholds in C. elegans models from Morley 2002."
Research Agent → searchPapers('Morley polyQ C. elegans') → Analysis Agent → runPythonAnalysis (extract threshold data, plot age-dependency with matplotlib) → statistical verification of dynamic toxicity.
"Write LaTeX review on trehalose autophagy enhancement for huntingtin clearance."
Synthesis Agent → gap detection (Sarkar 2006) → Writing Agent → latexEditText (draft section) → latexSyncCitations (add Rubinsztein papers) → latexCompile (PDF with figures) → exportBibtex.
"Find code for simulating protein aggregate propagation in neurodegeneration."
Research Agent → paperExtractUrls (Morley 2002) → Code Discovery → paperFindGithubRepo → githubRepoInspect (Python sims of prion-like seeding) → runPythonAnalysis (test aggregate growth models).
Automated Workflows
Deep Research workflow scans 50+ papers from Ross (2004) citation graph, producing structured report on aggregation pathways with GRADE scores. DeepScan's 7-step chain verifies autophagy claims from Sarkar et al. (2006) against Filimonenko (2007) via CoVe checkpoints. Theorizer generates hypotheses on aging-aggregate links from Morley (2002) and David (2010).
Frequently Asked Questions
What defines protein aggregation in neurodegeneration?
Misfolded proteins form insoluble inclusions from polyQ expansions or mutations, as in Huntington's (Ross and Poirier, 2004). Aggregates resist degradation, propagating prion-like.
What methods study aggregation clearance?
Autophagy enhancement with trehalose clears huntingtin (Sarkar et al., 2006). Multivesicular bodies require ESCRTs for aggregate autophagy (Filimonenko et al., 2007). C. elegans models test thresholds (Morley et al., 2002).
What are key papers?
Ross and Poirier (2004; 3415 citations) reviews aggregation-disease link. Nishitoh et al. (2002; 1326 citations) details ER stress-polyQ death. Sarkar et al. (2006; 1105 citations) shows trehalose efficacy.
What open problems exist?
Dynamic toxicity thresholds need precise quantification (Morley et al., 2002). Prion propagation blockers lack clinical translation. Aging-aggregate interplay requires human data beyond C. elegans (David et al., 2010).
Research Genetic Neurodegenerative Diseases with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Protein Aggregation in Neurodegeneration with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers